BR0009135A - Derivado de benzamida e medicamento que ocontém - Google Patents

Derivado de benzamida e medicamento que ocontém

Info

Publication number
BR0009135A
BR0009135A BR0009135-9A BR0009135A BR0009135A BR 0009135 A BR0009135 A BR 0009135A BR 0009135 A BR0009135 A BR 0009135A BR 0009135 A BR0009135 A BR 0009135A
Authority
BR
Brazil
Prior art keywords
drug
benzamide derivative
agent
gastrointestinal tract
derivative
Prior art date
Application number
BR0009135-9A
Other languages
English (en)
Inventor
Hideo Kato
Noriyuki Kado
Jun Sakaguchi
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Publication of BR0009135A publication Critical patent/BR0009135A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Abstract

Patente de Invenção "DERIVADO DE BENZAMIDA EMEDICAMENTO QUE O CONTéM". Caracterizado pelo fato decompreender um derivado de benzamida inovador representadopela fórmula geral a seguir: em que R representa um grupo alquilaque contém de três a seis átomos de carbono ou um de seus sais eum medicamento que compreende o mencionado derivado comoingrediente ativo. O medicamento possui excelente ação demelhoria da mobilidade do trato gastrointestinal e é disponíveloralmente com efeitos colaterais reduzidos. O medicamento é,portanto, extremamente útil como agente para o tratamentoterapêutico de doenças digestivas, agente para a melhoria dafunção de mobilidade do trato gastrointestinal e similares.
BR0009135-9A 1999-02-04 2000-02-02 Derivado de benzamida e medicamento que ocontém BR0009135A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2703099 1999-02-04
PCT/JP2000/000560 WO2000046201A1 (fr) 1999-02-04 2000-02-02 Dérivés de benzamide et médicaments les contenant

Publications (1)

Publication Number Publication Date
BR0009135A true BR0009135A (pt) 2001-11-27

Family

ID=12209686

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009135-9A BR0009135A (pt) 1999-02-04 2000-02-02 Derivado de benzamida e medicamento que ocontém

Country Status (28)

Country Link
US (2) US6638951B1 (pt)
EP (1) EP1149832B1 (pt)
KR (1) KR100775344B1 (pt)
CN (1) CN1126738C (pt)
AR (1) AR022338A1 (pt)
AT (1) ATE230397T1 (pt)
AU (1) AU755124B2 (pt)
BG (1) BG65512B1 (pt)
BR (1) BR0009135A (pt)
CA (1) CA2362211C (pt)
CO (1) CO5170447A1 (pt)
CZ (1) CZ298219B6 (pt)
DE (1) DE60001100T2 (pt)
DK (1) DK1149832T3 (pt)
ES (1) ES2189736T3 (pt)
HK (1) HK1044947B (pt)
HU (1) HUP0105359A3 (pt)
IL (2) IL144525A0 (pt)
MX (1) MXPA01007705A (pt)
MY (1) MY122570A (pt)
NO (1) NO319791B1 (pt)
PL (1) PL203831B1 (pt)
PT (1) PT1149832E (pt)
SK (1) SK285679B6 (pt)
TR (1) TR200102082T2 (pt)
TW (1) TW527347B (pt)
WO (1) WO2000046201A1 (pt)
ZA (1) ZA200107244B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001093849A2 (en) * 2000-06-07 2001-12-13 Aryx Therapeutics Treatment of gastroesophageal reflux disease using piperidine derivatives
AU2004303722B2 (en) 2003-12-23 2010-02-18 Serodus As Modulators of peripheral 5-HT receptors
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
DE602005020580D1 (de) * 2004-01-07 2010-05-27 Aryx Therapeutics Stereoisomere verbindungen und verfahren zur behandlung von erkrankungen des magen-darm-trakts und des zentralen nervensystems
EP1919909B1 (en) 2005-08-31 2013-08-21 Armetheon, Inc. Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
EP2027087A2 (en) 2006-05-18 2009-02-25 MannKind Corporation Intracellular kinase inhibitors
WO2007149929A1 (en) * 2006-06-23 2007-12-27 Aryx Therapeutics, Inc. Piperidine derivatives for the treatment of gastrointestinal and cns disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718345D0 (en) 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
JP3104142B2 (ja) 1991-02-15 2000-10-30 北陸製薬株式会社 ベンズアミド誘導体
TW213460B (pt) 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5395832A (en) 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
JPH11292846A (ja) 1998-02-10 1999-10-26 Hokuriku Seiyaku Co Ltd ベンズアミド誘導体及びそれを含有する医薬

Also Published As

Publication number Publication date
CO5170447A1 (es) 2002-06-27
TR200102082T2 (tr) 2002-01-21
HK1044947B (zh) 2004-07-23
MXPA01007705A (es) 2003-06-24
CA2362211A1 (en) 2000-08-10
AU755124B2 (en) 2002-12-05
CZ20012759A3 (cs) 2002-01-16
DE60001100D1 (de) 2003-02-06
SK10912001A3 (sk) 2002-02-05
DE60001100T2 (de) 2003-11-13
NO20013816D0 (no) 2001-08-03
DK1149832T3 (da) 2003-04-22
BG65512B1 (bg) 2008-10-31
US6638951B1 (en) 2003-10-28
CZ298219B6 (cs) 2007-07-25
KR100775344B1 (ko) 2007-11-08
KR20010101996A (ko) 2001-11-15
ES2189736T3 (es) 2003-07-16
NO20013816L (no) 2001-08-03
HUP0105359A3 (en) 2002-12-28
ATE230397T1 (de) 2003-01-15
SK285679B6 (sk) 2007-06-07
AR022338A1 (es) 2002-09-04
AU2324400A (en) 2000-08-25
CA2362211C (en) 2008-11-25
IL144525A0 (en) 2002-05-23
ZA200107244B (en) 2002-06-26
IL144525A (en) 2006-04-10
BG105835A (bg) 2002-05-31
CN1126738C (zh) 2003-11-05
PT1149832E (pt) 2003-04-30
WO2000046201A1 (fr) 2000-08-10
HK1044947A1 (en) 2002-11-08
HUP0105359A2 (hu) 2002-05-29
EP1149832B1 (en) 2003-01-02
CN1339026A (zh) 2002-03-06
PL349133A1 (en) 2002-07-01
US20040087622A1 (en) 2004-05-06
MY122570A (en) 2006-04-29
NO319791B1 (no) 2005-09-12
TW527347B (en) 2003-04-11
EP1149832A4 (en) 2002-04-10
EP1149832A1 (en) 2001-10-31
PL203831B1 (pl) 2009-11-30

Similar Documents

Publication Publication Date Title
BRPI0510414A (pt) uso de derivados de quinolina substituìdos para o tratamento de doenças micobacterianas resistentes a fármacos
KR920019342A (ko) 골질환 치료제
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
BR0310006A (pt) Derivados de 5-tio-beta-d-glicopiranosìdeo de arila e agentes terapêuticos para diabetes contendo os mesmos
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BRPI0418074B8 (pt) derivado de amida, composição farmacêutica, inibidor da tirosina cinase bcr-abl e agentes terapêuticos
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
DK0583421T3 (da) Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
SE9901573D0 (sv) New compounds
ES2139673T3 (es) Utilizacion de norastemizol para el tratamiento de rinitis alergica.
BR0013793A (pt) Medicamentos profiláticos e terapêuticos para doenças oftálmicas
DE69322251D1 (de) Medizinische zusammensetzung
BR0009135A (pt) Derivado de benzamida e medicamento que ocontém
BR0102940A (pt) Agente para o tratamento de doença de parkinson compreendendo um agente de melhora da função de astrócitos como ingrediente ativo
SE9901572D0 (sv) New compounds
HUP0201282A2 (hu) Hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítmények dermatitisz megelőzésére és kezelésére
KR960034190A (ko) N-아실피페라진 유도체 및 항균제, 항궤양제
BR0116263A (pt) Derivados de diidroindol e tetraidroquinolina
FI964303A0 (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
BR0009327A (pt) Composição farmacêutica para a terapia de sintomas do trato urinário inferior
NO20013480D0 (no) Legemiddel for törr hud
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
TH59380B (th) อนุพันธ์ของเบนซามีด และยาซึ่งมีสารชนิดเดียวกันนี้อยู่ด้วย
TH50173A (th) การใช้ 1-ไฮดรอกซี-2-ไพริโดนสำหรับการบำบัดการติดเชื้อที่ผิวหนัง
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ABBOTT JAPAN CO., LTD (JP)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 11 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]